St John's wort and DOAC — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — St John's wort can reduce apixaban exposure and anticoagulant effect
St John's wort induces drug-metabolising enzymes and transporters and can reduce exposure to some anticoagulants, including DOACs. Reduced anticoagulant effect could increase thrombosis risk. The patient should be advised not to use it and to discuss mood symptoms with a healthcare professional.
Reference: BNF